1. Home
  2. SPRU vs CLNN Comparison

SPRU vs CLNN Comparison

Compare SPRU & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRU
  • CLNN
  • Stock Information
  • Founded
  • SPRU 2008
  • CLNN 2012
  • Country
  • SPRU United States
  • CLNN United States
  • Employees
  • SPRU N/A
  • CLNN N/A
  • Industry
  • SPRU Auto Parts:O.E.M.
  • CLNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRU Consumer Discretionary
  • CLNN Health Care
  • Exchange
  • SPRU Nasdaq
  • CLNN Nasdaq
  • Market Cap
  • SPRU 42.5M
  • CLNN 43.0M
  • IPO Year
  • SPRU N/A
  • CLNN N/A
  • Fundamental
  • Price
  • SPRU $2.39
  • CLNN $4.53
  • Analyst Decision
  • SPRU
  • CLNN Strong Buy
  • Analyst Count
  • SPRU 0
  • CLNN 4
  • Target Price
  • SPRU N/A
  • CLNN $59.25
  • AVG Volume (30 Days)
  • SPRU 42.1K
  • CLNN 54.9K
  • Earning Date
  • SPRU 11-13-2024
  • CLNN 11-13-2024
  • Dividend Yield
  • SPRU N/A
  • CLNN N/A
  • EPS Growth
  • SPRU N/A
  • CLNN N/A
  • EPS
  • SPRU N/A
  • CLNN N/A
  • Revenue
  • SPRU $79,719,000.00
  • CLNN $421,000.00
  • Revenue This Year
  • SPRU $3.51
  • CLNN N/A
  • Revenue Next Year
  • SPRU $2.00
  • CLNN $1,058.37
  • P/E Ratio
  • SPRU N/A
  • CLNN N/A
  • Revenue Growth
  • SPRU 24.36
  • CLNN N/A
  • 52 Week Low
  • SPRU $2.17
  • CLNN $3.82
  • 52 Week High
  • SPRU $4.89
  • CLNN $12.00
  • Technical
  • Relative Strength Index (RSI)
  • SPRU 43.22
  • CLNN 34.27
  • Support Level
  • SPRU $2.17
  • CLNN $5.00
  • Resistance Level
  • SPRU $2.59
  • CLNN $6.04
  • Average True Range (ATR)
  • SPRU 0.13
  • CLNN 0.52
  • MACD
  • SPRU -0.00
  • CLNN -0.17
  • Stochastic Oscillator
  • SPRU 46.12
  • CLNN 8.80

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is a leading owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to approximately 75,000 home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's primary customers are homeowners and the Company's core solar service offerings generate revenues primarily through (i) the sale of electricity generated by its home solar energy systems to homeowners, (ii) third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and (iii) the servicing of those agreements for other institutional owners of home solar energy systems.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).

Share on Social Networks: